Archive for January, 2010

Lexiscan (Regadenoson Injection) - updated on RxList

Lexiscan (Regadenoson Injection) drug description - FDA approved labeling for prescription drugs and medications at RxList

Read the rest of this entry »

Janumet (Sitagliptin Metformin HCL) - updated on RxList

Janumet (Sitagliptin Metformin HCL) drug description - FDA approved labeling for prescription drugs and medications at RxList

Read the rest of this entry »

Lovenox (Enoxaparin Sodium Injection) - updated on RxList

Lovenox (Enoxaparin Sodium Injection) drug description - FDA approved labeling for prescription drugs and medications at RxList

Read the rest of this entry »

Forest And Almirall Announce Positive Results From The ACCORD COPD I Phase III Study Of Aclidinium Bromide In Chronic Obstructive Pulmonary Disease

Forest Laboratories, Inc. (NYSE: FRX) and Almirall, S.A. (ALM.MC) today announced positive top-line results from ACCORD COPD I, a three-month Phase III study comparing aclidinium 200µg and 400µg BID versus placebo. Aclidinium bromide produced statistically significant (p Aclidinium was well tolerated in this study…

Read the rest of this entry »

Also In Global Health News: ART Access In Zimbabwe; Indonesia Bird Flu Deaths; Kenya Floods; Solomon Island Tsunami

Zimbabwe Wants To Boost Access To ART By End Of 2010, Health Minister Says Zimbabwe’s government plans work with international organizations to increase the number of people receiving anti-retroviral therapy (ART) to 300,000 by the end of the year, up from the 180,000 who currently [...]

Read the rest of this entry »

Ipratropium Bromide May Increase Risk For Cardiovascular Events

Patients taking ipratropium bromide, an anticholinergic used in the treatment of COPD, may be at an increased risk for cardiovascular events (CVE), including heart failure. Researchers from the University of Washington in Seattle, WA, and Hines VA Hospital in Hines, IL, conducted a cohort study on 82,717 US veterans with a new diagnosis of COPD [...]

Read the rest of this entry »

Tiotropium Associated With Reduced Mortality

New research suggests that tiotropium, a long-acting anticholinergic used in patients with COPD, may be associated with a reduction in all-cause mortality, cardiovascular mortality, and cardiovascular events. Researchers from Caritas-St. Elizabeth Medical Center in Boston, MA, reviewed the outcomes of 30 completed clinical trials in the tiotropium project database…

Read the rest of this entry »

New Schedule for Childhood Vaccines

Changes have been made to the childhood vaccine schedule to include a meningitis vaccine booster and an HPV vaccine to boys as well as to girls.

Read the rest of this entry »

Get Mammograms Early and Often

Radiologists say women need annual mammograms starting no later than age 40–-against the new breast-cancer screening advice from an HHS panel.

Read the rest of this entry »

New Brain Scan May Predict Alzheimer's

Early signs of Alzheimer's diseases may be predicted with an imaging technique that measures random motion of water in the brain.

Read the rest of this entry »